SINOVAC BIOTECH LTD Additional Paid in Capital, Common Stock
SINOVAC BIOTECH LTD (SVA) had Additional Paid in Capital, Common Stock of $550.17 million as of 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-06-05
- 2025-12-31: Additional Paid in Capital, Common Stock $550.17M.
- 2024-12-31: Additional Paid in Capital, Common Stock $550.17M.
- 2023-12-31: Additional Paid in Capital, Common Stock $550.17M; Additional Paid in Capital, Common Stock as first filed $541.26M.
- 2022-12-31: Additional Paid in Capital, Common Stock $549.49M; Additional Paid in Capital, Common Stock as first filed $540.58M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2025-12-31 | $550.17M 20-F · filed 2026-06-05 | |
| 2024-12-31 | $550.17M 20-F · filed 2026-06-05 | |
| 2023-12-31 | $550.17M 20-F · filed 2026-04-30 | $541.26M 20-F · filed 2024-04-29 |
| 2022-12-31 | $549.49M 20-F · filed 2026-04-30 | $540.58M 20-F · filed 2023-05-01 |
| 2021-12-31 | $544.60M 20-F · filed 2026-04-30 | $547.69M 20-F · filed 2022-04-29 |
| 2020-12-31 | $538.92M 20-F · filed 2022-04-29 | |
| 2019-12-31 | $207.96M 20-F · filed 2021-04-22 | |
| 2018-12-31 | $205.00M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $115.34M 20-F · filed 2019-04-29 | |
| 2016-12-31 | $112.67M 20-F · filed 2018-05-11 | |
| 2015-12-31 | $109.94M 20-F · filed 2017-11-22 | |
| 2014-12-31 | $108.24M 20-F · filed 2016-04-25 | |
| 2013-12-31 | $107.39M 20-F · filed 2015-04-29 | |
| 2012-12-31 | $106.25M 20-F · filed 2014-04-16 | $106.25M 20-F/A · filed 2013-05-23 |
| 2011-12-31 | $105.38M 20-F/A · filed 2013-05-23 | |
| 2010-12-31 | $104.15M 20-F · filed 2012-04-12 |